Access Bio (Korea) Market Value
| 950130 Stock | KRW 5,570 10.00 0.18% |
| Symbol | Access |
Access Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Access Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Access Bio.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in Access Bio on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding Access Bio or generate 0.0% return on investment in Access Bio over 720 days. Access Bio is related to or competes with Lotte Data, E Investment, SK Telecom, Korean Air, SBI Investment, Coloray International, and Nice Information. Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. More
Access Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Access Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Access Bio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 20.5 | |||
| Value At Risk | (5.31) | |||
| Potential Upside | 4.38 |
Access Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Access Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Access Bio's standard deviation. In reality, there are many statistical measures that can use Access Bio historical prices to predict the future Access Bio's volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (2.57) |
Access Bio Backtested Returns
Access Bio secures Sharpe Ratio (or Efficiency) of -0.19, which signifies that the company had a -0.19% return per unit of standard deviation over the last 3 months. Access Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Access Bio's risk adjusted performance of (0.14), and Mean Deviation of 2.17 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.24, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Access Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Access Bio is expected to be smaller as well. At this point, Access Bio has a negative expected return of -0.43%. Please make sure to confirm Access Bio's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Access Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.52 |
Modest predictability
Access Bio has modest predictability. Overlapping area represents the amount of predictability between Access Bio time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Access Bio price movement. The serial correlation of 0.52 indicates that about 52.0% of current Access Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | 0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 1.4 M |
Access Bio lagged returns against current returns
Autocorrelation, which is Access Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Access Bio's stock expected returns. We can calculate the autocorrelation of Access Bio returns to help us make a trade decision. For example, suppose you find that Access Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Access Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Access Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Access Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Access Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Access Bio Lagged Returns
When evaluating Access Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Access Bio stock have on its future price. Access Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Access Bio autocorrelation shows the relationship between Access Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Access Bio.
Regressed Prices |
| Timeline |
Pair Trading with Access Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Access Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Access Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Access Stock
Moving against Access Stock
| 0.55 | 032830 | Samsung Life | PairCorr |
| 0.47 | 024110 | Industrial Bank | PairCorr |
| 0.35 | 105560 | KB Financial Group | PairCorr |
The ability to find closely correlated positions to Access Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Access Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Access Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Access Bio to buy it.
The correlation of Access Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Access Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Access Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Access Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Access Stock
Access Bio financial ratios help investors to determine whether Access Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Access with respect to the benefits of owning Access Bio security.